Skip to main content
. 2021 Aug 4;88(Suppl 5):S32–S41. doi: 10.1016/j.bjorl.2021.06.008

Table 1.

Characteristics of patients according to the presence of polyps.

Characteristic Type of chronic rhinosinusitis
Test p-Value
CRSwNP
CRSnNP
Total
n = 205 n = 52 n = 257
Age (years) M/SD 55.2 13.4 56.9 12.4 55.5 13.2 T 0.38
Female gender n (%) 101 49.3 36 69.2 137 53.3 Chi 0.01a
Main symptom
Nasal obstruction n (%) 78 38.1 19 36.5 97 37.7 Chi 1
Anterior rhinorrhea n (%) 29 14.2 16 30.1 45 17.5 Chi 0.005a
Posterior rhinorrhea n (%) 14 6.8 2 3.9 16 6.2 Chi 0.54
Hyposmia n (%) 69 33.7 4 7.7 73 28.4 Chi 0.0002a
Facialgia n (%) 11 5.4 11 21.2 22 8.6 Fisher 0.001a
Irritation symptoms n (%) 4 2.0 0 0.0 2 0.8 Fisher 0.59
Comorbidities
Asthma n (%) 87 42.4 5 9.6 92 35.8 Chi 0.0001a
ASA intolerance n (%) 30 14.6 1 1.9 31 12.1 Chi 0.01a
NSAID intolerance n (%) 19 9.3 1 1.9 20 7.8 Fisher 0.09
Dipyrone intolerance n (%) 28 13.7 1 1.9 29 11.3 Chi 0.02a
NERD n (%) 28 13.7 1 1.9 29 11.3 Chi 0.02a
AFRS n (%) 2 1.0 0 0.0 2 0.8 Fisher 1
Active smoker n (%) 12 5.9 4 7.7 16 6.2 Fisher 0.75
Ex-smoker n (%) 25 12.2 7 13.5 32 12.5 Chi 0.81
Previous ESS n (%) 131 63.9 31 59.6 162 63.0 Chi 0.57
CSNI n (%) 87 42.4 21 40.4 108 42.0 Chi 0.79
CSNS n (%) 118 57.6 31 59.6 149 58.0 Chi 0.79

CRSwNP, chronic rhinosinusitis with nasal polyps; CRSnNP, chronic rhinosinusitis without nasal polyps; M, mean; SD, standard deviation; n, number; %, percentage; ASA, acetylsalicylic acid; NSAIDs, non-steroidal anti-inflammatory drugs; NERD, NSAID-exacerbated respiratory disease; AFRS, allergic fungal rhinosinusitis; ESS, endoscopic sinus surgery; CSNI, corticosteroid nasal irrigation; CS, corticosteroid.

a

p < 0.05.